A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma

计划入组 30 人 · 首次发布于 2025 年 7 月 25 日

10°C vs 4°C Lung Preservation RCT

计划入组 300 人 · 首次发布于 2023 年 6 月 12 日

Complications: Urgent C Section VS Elective C Section

计划入组 240 人 · 首次发布于 2012 年 2 月 1 日

Adze-1.17.C

C 135LS/C 144LS

Lanatoside C

C₄₉H₇₆O₂₀

C & C Oxygen Company

United States

Buchanan C Michael

United States

DENVER NEPHROLOGISTS P C

United States

Adze Biotechnology Receives Ethics Approval for Phase I Oncolytic Immunotherapy Trial in Metastatic Melanoma

Advancements in Clostridioides difficile Treatment and Prevention Highlighted in 2024

Akeso's Phase 3 Trial Begins for Ivonescimab and Ligufalimab Combination in Head and Neck Cancer